Почетна › Рак дојке › Тенеси › Memphis
Kliničke studije za Рак дојке u gradu Memphis, TN
Jedna studija za Рак дојке traži učesnike na lokaciji u gradu Memphis ili u blizini. Otvorite je da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
Тражи се учесникФаза 2
- West Cancer Center & Research Institute, Germantown · 14 ми удаљено
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Тражи се учесник
- The West Clinic, PC dba West Cancer Center, Germantown · 14 ми удаљено
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Тражи се учесникФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Тражи се учесникФаза 2
- West Cancer Center (Margaret West Comprehensive Breast Center), Memphis
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Тражи се учесникФаза 1/2
- The West Clinic, Germantown · 14 ми удаљено
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Тражи се учесникФаза 1/2
- Baptist Cancer Center - Memphis, Memphis
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Тражи се учесник
- West Cancer Center, Germantown · 14 ми удаљено
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Тражи се учесникФаза 3
- West Cancer Center, Germantown · 14 ми удаљено
E-Mindfulness Approaches for Living After Breast Cancer
Тражи се учесникФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 ми удаљено
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Тражи се учесникОпсервациона студија
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital for Women, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southaven · 11 ми удаљено
- и још 1
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Тражи се учесникФаза 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 ми удаљено
- The West Clinic - Wolf River, Germantown · 14 ми удаљено
- и још 1
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Тражи се учесникФаза 3
- Baptist Memorial Healthcare, Memphis
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Тражи се учесникФаза 3
- The West Clinic, P.C. dba West Cancer Center, Germantown · 14 ми удаљено
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
Тражи се учесникФаза 2
- West Cancer Center, Germantown · 14 ми удаљено
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Тражи се учесникФаза 3
- The West Clinic, PLLC dba West Cancer Center, Germantown · 14 ми удаљено
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Тражи се учесникФаза 1/2
- The West Cancer Center, Memphis
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Тражи се учесникФаза 3
- Clinical Trial Site, Bartlett · 11 ми удаљено
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- The West Clinic, PLLC dba West Cancer Center, Germantown · 14 ми удаљено
Familial Investigations of Childhood Cancer Predisposition
Тражи се учесникОпсервациона студија
- St. Jude Children's Research Hospital, Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Memphis
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Тражи се учесникОпсервациона студија
- West Cancer Center, Germantown · 14 ми удаљено
Studije za Рак дојке u drugim gradovima
- New York City, NY144 студија
- Houston, TX126 студија
- Boston, MA110 студија
- Nashville, TN78 студија
- Los Angeles, CA73 студија
- Edison, NJ70 студија
- Queens, NY67 студија
- Durham, NC63 студија
- St. Louis, MO63 студија
- Chicago, IL59 студија
- Dallas, TX54 студија
- Philadelphia, PA51 студија
Ostale studije u gradu Memphis
- Рак (све врсте)30 студија
- Немалоклетни карцином плућа25 студија
- Srpastoćelijska bolest19 студија
- Akutna limfoblastna leukemija17 студија
- Рак плућа17 студија
- Akutna mijeloidna leukemija14 студија
- Затајење срца12 студија
- Меланом11 студија
- Сарком меког ткива10 студија
- Колоректални карцином10 студија
- Dijabetes tipa 210 студија
- Остеосарком10 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.